This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Q2 revenue rises 20%, profit falls; hospital expansion approved
MAXHEALTH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.5 pts more than Nifty 100 and 0.9 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Q2 consolidated revenue rose 20.3% to ₹256,921 lakh from ₹213,547 lakh, but profit after tax fell 15.7% to ₹41,445 lakh; the prior year had a ₹5,556 lakh deferred tax credit. H1 consolidated revenue rose 18.6% to ₹493,538 lakh, while profit fell 7.4% to ₹73,741 lakh. Board approved ₹93 crore for Noida and ₹97 crore for Vaishali; Gurugram project cost was revised to ₹1,143 crore, with completion in April 2027. Review reports were unmodified.
Revenue growth and new hospital capacity support the long-term case, but lower profit and major capital spending may weigh on near-term returns.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹2,569 Cr | ₹2,135 Cr | +20.3% |
| Operating profit | ₹500.0 Cr | ₹413.1 Cr | +21.0% |
| Profit after tax | ₹414.5 Cr | ₹491.3 Cr | −15.6% |
| EBITDA margin | 27.7% | 26.9% | +0.8 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.